CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Mayinglong Pharmaceutical Group Co Ltd Company Snapshot
Mayinglong Pharmaceutical Group Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mayinglong Pharmaceutical Group Co Ltd with three other companies in this sector in China: SSY Group Ltd (2016 sales of 2.02 billion Chinese Renmimbi [US$305.76 million] of which 94% was Intravenous Infusion Solution and Others), Anhui Fengyuan Pharmaceutical (2.03 billion Chinese Renmimbi [US$307.17 million] of which 63% was Medicine Retail Circulation), and Hengkang Medical Group Co Ltd (2.18 billion Chinese Renmimbi [US$328.57 million] of which 57% was Service).

Sales Analysis. Mayinglong Pharmaceutical Group Co Ltd reported sales of 2.10 billion Chinese Renmimbi (US$317.61 million) for the year ending December of 2016. This represents an increase of 17.9% versus 2015, when the company's sales were 1.78 billion Chinese Renmimbi. Sales at Mayinglong Pharmaceutical Group Co Ltd have increased during each of the previous five years (and since 2011, sales have increased a total of 49%). Sales of the Hospital Diagnosis and Treatment saw an increase of 21.7% in 2016, from 117.21 million Chinese Renmimbi to 142.66 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Mayinglong Pharmaceutical Group Co Ltd
  Stock Performance Chart for Mayinglong Pharmaceutical Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 20.94
(Figures in Chinese Renmimbi)
1 Week -3.1%   13 Weeks -8.3%  
4 Weeks 2.1%   52 Weeks 2.1%  
 
Mayinglong Pharmaceutical Group Co Ltd Key Data:
  Ticker: 600993 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 2,102,544,432
(Year Ending Jan 2017).
Employees: 3,079
  Currency: Chinese Renmimbi Market Cap: 9,026,268,478
  Fiscal Yr Ends: December Shares Outstanding: 431,053,891
  Share Type: A Shares Closely Held Shares: 161,091,304
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.